Company page

Bioasis Technologies Inc.

Bioasis Technologies Inc. is a public company traded under the ticker BIOAF in the American market. The company focuses on developing innovative therapies for neurological diseases using its proprietary technology platform. Bioasis aims to enhance drug delivery to the brain, addressing significant unmet medical needs in the field of neurology.

profileBIOAF:OTCAI content: aiUpdated June 24, 2026/company/bioasis-technologies-inc/c-wj1fxxry
Bioasis Technologies Inc. logo
Ticker
BIOAF:OTC
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OTC
Currency
USD